Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma

BACKGROUND: Standard pre- and postcontrast (T1 + C) anatomical MR imaging is proving to be insufficient for accurately monitoring bevacizumab treatment response in recurrent glioblastoma (GBM). We present a novel imaging biomarker that detects abnormal tumor vasculature exhibiting both arterial and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: LaViolette, Peter S., Cohen, Alex D., Prah, Melissa A., Rand, Scott D., Connelly, Jennifer, Malkin, Mark. G., Mueller, Wade. M., Schmainda, Kathleen M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2013
Soggetti:
Basic and Translational Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607265/
https://ncbi.nlm.nih.gov/pubmed/23382287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos323
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi